ConCallIQ
Go Pro
APOLLOTYRE Diversified 15 May 2026

Apollo Tyres Limited — Q4 FY26

Apollo Tyres reported a strong Q4 FY26 with consolidated revenue of ₹7,340 crore (+14% YoY) and EBITDA margin of 14.6% (+160bps YoY).

neutral medium
Compare with...
Revenue ₹7,340 Cr +14%
EBITDA ₹1,070 Cr
PAT ₹631 Cr
EBITDA Margin 14.6% +160bps
Duration 46 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Apollo Tyres reported a strong Q4 FY26 with consolidated revenue of ₹7,340 crore (+14% YoY) and EBITDA margin of 14.6% (+160bps YoY). India operations drove growth with high-teens volume growth in replacement and OE, while Europe remained muted with revenue down 1% YoY. The company announced a ₹3,500 crore capex for FY27, with 80% towards capacity expansion. However, raw material costs are expected to rise mid-to-high teens sequentially in Q1 FY27, prompting price hikes of 6-8% already announced, with more needed. The closure of the Enschede plant is on track, with a non-cash write-off of €43 million. Key risk: sustained commodity inflation could pressure margins if price hikes lag, especially given volatile geopolitical conditions in West Asia.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Commodity inflation may outpace price hikes

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

India standalone revenue ₹5,240 crore
+14.3% YoY

India revenue grew 14.3% YoY to ₹5,240 crore, driven by strong volume growth in replacement and OE.

Europe revenue €170 million
-1% YoY

Europe revenue declined 1% YoY due to muted market conditions and supply issues from India.

Capacity utilization 90%
flat

Capacity utilization remained high at 90% across India and Europe, limiting ability to meet demand.

Net debt to EBITDA 0.4x
-2.8x YoY

Net debt to EBITDA improved from 3.2x to 0.4x, reflecting strong cash flow and deleveraging.

What Changed vs Last Quarter

Comparing Q4 FY26 vs Q3 FY26
3 new guidance2 dropped4 new risk4 risk resolved
NEW
Price hikes of 6-8% in Q1 FY27, more needed

Price increases of 6-8% announced for Q1 FY27, with at least two more rounds required to offset raw material cost inflation.

NEW
Europe margins to improve in H2 FY27 post restructuring

Positive impact on European margins expected from H2 FY27 after Enschede closure and stabilization.

NEW
Raw material costs to rise mid-to-high teens sequentially in Q1

Raw material costs expected to increase mid-to-high teens in Q1 FY27 vs Q4 FY26, with further pressure possible in Q2.

UPDATED
FY27 capex of ₹3,500 crore, 80% for growth

Capex of ₹3,500 crore planned for FY27, with nearly 80% allocated to capacity expansion in India and Hungary.

DROPPED
Capex of ₹5,800 crore for Andhra plant over FY27-29

Board approved ₹5,800 crore capex for expanding PCR and TBR capacities at the Andhra plant, spread over three financial years.

DROPPED
A&P spend to normalize to 2.5% of sales by FY27

Elevated A&P spend in Q3 (₹150 crore) will normalize to about 2.5% of sales in a steady state from FY27 onwards.

NEW RISK
Commodity inflation may outpace price hikes

Raw material costs rising mid-to-high teens sequentially, with only 6-8% price hikes announced; further increases needed but timing uncertain.

NEW RISK
Geopolitical volatility in West Asia

Geopolitical developments add uncertainty to raw material, energy, and logistics costs, potentially impacting margins further.

NEW RISK
Demand slowdown from price and fuel increases

Analyst raised concern that price hikes and diesel price increases could impact fleet operator profitability and demand in H2 FY27.

NEW RISK
Europe revenue loss from Enschede closure

Closure of Enschede plant may result in loss of agricultural tire OE business, estimated at ~5% of Europe revenue.

RISK GONE
Raw material cost volatility

International commodity prices and currency fluctuations could increase raw material costs, pressuring margins. Management noted flattish outlook but acknowledged unpredictability.

RISK GONE
Elevated A&P spend impacting near-term margins

Q3 A&P spend was ₹150 crore (elevated due to BCCI sponsorship activation), and Q4 will also be high, delaying margin normalization to FY27.

RISK GONE
Europe demand remains weak

European market growth was negative (-4% for PCR), and recovery is uncertain, limiting topline growth in that region.

RISK GONE
High capex cycle may pressure return ratios

The ₹5,800 crore capex over FY27-29 will increase debt and depreciation, potentially delaying RoCE improvement towards the 15% target.

Fast read

Guidance and risk preview

Top guidance FY27 capex of ₹3,500 crore, 80% for growth

Capex of ₹3,500 crore planned for FY27, with nearly 80% allocated to capacity expansion in India and Hungary.

Top risk Commodity inflation may outpace price hikes

Raw material costs rising mid-to-high teens sequentially, with only 6-8% price hikes announced; further increases needed but timing uncertain.

View Risks →